📌 Key Takeaways
- Topic: Silica for Rheology Control: How to Select the Right Silica and Dosage
- Keywords: silica aerogel insulation
- Published: 2026-11-20 12:34:24
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica for Rubber: Reinforcement Benefits, Grades and Compounding Tips
- Is Silica in Cosmetics Safe? Ingredient Safety and Regulatory Status
- Fumed Silica 200 m²/g: Properties, Typical Uses and Comparable Grades
- Silica for Skincare: Benefits for Oil Control, Texture and Soft-Focus Effects
- Clinical trials involving mesoporous silica have been ongoing since 2007, discussing its potential in diverse biomedical applications (Table 3 ). To date, the clinical trials have revealed the safety and good tolerability of silica in human subjects. In 2014, MSNs as oral delivery carriers for boosting the pharmacokinetic profile of drugs with limited aqueous solubility were reported. 500 A silica NPs-lipid hybrid formulation loading with ibuprofen (Lipoceramic-IBU) was prepared. The randomized, double-blind, single-dose oral administration study (20 mg ibuprofen) was conducted on 16 healthy male volunteers. The bioavailability of Lipoceramic-IBU was found to be 1.95 times higher than that of the commercial tablet Nurofen. 500 This result suggested the secure and effective use of silica-based NPs in mimicking food impacts to optimize the oral absorption of drugs with poor water solubility. In another clinical trial consisting of 12 participants in 2016, the bioavailability of ordered MSNs-based fenofibrate formulation raised by 54.1% after a single oral dose, when compared to the commercial formulation Lipanthyl. 39 Owing to the potentially perfect clinical outcomes of silica-based nanocarriers, the pharmacokinetics, safety, and metabolic profile of a hybrid core-shell silica NP (named Cornell dots, C dots) with a diameter of 6 nm functionalized with 124 I, targeting peptide cyclo-(Arg-Gly-Asp-Tyr), and Cy5 ( 124 I-cRGDY-PEG-C' dots) is first conducted in humans utilizing PET imaging and clinical tracer at clinical trials in 2014 (NCT01266096). 58 Results showed the good safety and reproducible PK signatures of C dots with the whole-body clearance half-time of 13-21 h after intravenous administration in patients, which is shorter than 111 In labeled liposomes and 131 I-labeled humanized monoclonal antibody A33. These findings verified the possibility of these NPs for cancer diagnostics in humans. 58 Similarly, 8 nm core-shell silica NPs encapsulated with Cy5.5 in the core and connected with cRGDY on the surface (cRGDY-PEG-Cy5.5-nanoparticles) were used in patients at nanomole doses for sentinel lymph nodes detection of head and neck melanoma at a phase 1/2 human clinical trial. 501 The incredible safety, accuracy, reliability, and high contrast of these particles for visual identification of sentinel lymph nodes are irreplaceable by other available imaging molecules presently, of which phase 2 clinical trial is ongoing and will be finished in 2024 (NCT02106598). Meanwhile, another two clinical trials based on C dots are carried out. In 2018, the 89 Zr-DFO-cRGDY-PEG-Cy5-C' dots tracers were first used in both surgical and non-surgical patients for PET-CT imaging of malignant brain tumors in phase 1 clinical trial (NCT03465618). The distribution and removal profiles from the body of these particles will also be assessed till 2023. In 2019, 64 Cu-NOTA-PSMA-PEG-Cy5.5-C' dots tracer was used in another human phase 1 clinical trial for guiding the surgery of prostate cancer by PET and MRI imaging (NCT04167969).As a nanocomposite with high safety and brilliant photothermal conversion efficiency, the silica-gold NPs have also been shown to be potential therapeutic agents for plasmonic photothermal therapy of atherosclerosis (NCT01270139), 502, 503 and photothermal ablation of tumors (NCT00848042, NCT04240639). 40 In addition, an engineered mesoporous silica (SiPore15) with particle size of 1.1-1.5 μm × 0.2-0.4 μm was developed by Baek et al., and they revealed that such pure synthetic amorphous silica could remarkably decrease long-term blood glucose levels, showing good promise for the treatment of prediabetes (NCT03823027). 504 In other clinical trials, an amorphous silica-containing bioactive scaffold, called Siloss, was used to promote bone regeneration, and could be replaced by natural bone due to its fully resorbable nature (NCT02639572), and the silica-calcium phosphate nanocomposite (SCPC) was developed as graft material for the reconstruction of the volume-deficient alveolar ridges (NCT05317039). In all, these clinical trials reveal the safety and efficacy of MSNs in diverse biomedical application scenarios.
- Foundry Silica Sand: AFS Grain Fineness, Specifications and Uses
Silica Manufacturer in China: How to Evaluate Quality, Capacity and Export Experience
What is silica (SiO₂)?
silica supplier Mexico In this process, nanozymes are capable of following enzyme kinetics under physiological conditions and catalyzing the conversion of enzyme substrates by mimicking the structure or function of natural enzymes. Current nanozymes are dominated by oxidoreductase activity, i.e., oxidative stress amplification-related POD or OXD mimics, 423, 424 and antioxidation-related CAT or SOD mimics. 425, 426 By designing nanozymes with various catalytic activities, the redox balance of cells can be precisely regulated, i.e., enhanced ROS generation or ROS scavenging, enabling symptomatic treatment in a variety of disease models. 427, 428, 429, 430 Owing to the rich and tunable pore structure, MSNs have become a brilliant nanoreactor in enzyme-like catalytic therapy. 431, 432, 433, 434, 435 In a study by Wu et al., MSNs were developed as a compartmental hierarchical nanoreactor for multi-pathway generation of 1 O 2. Specifically, they designed a compartmental multienzyme nanoreactor with penetrated super cavity and connected dual mesoporous channels for the encapsulation of a multi-enzyme complex (SOD-lactoperoxidase (LPO)) and a photosensitizer ICG molecule. The cascade biocatalysis and enzyme-enhanced photosensitization could occur in parallel, due to the unimpeded substrate diffusion between SOD and LPO and reduced external diffusion effects. This strategy offers unique perks in the treatment of hypoxia tumors. 436 In terms of MSNs-based ROS elimination platform, Purikova et al. filled ultrasmall cerium dioxide (CeO 2 ) NPs with superior colloidal stability into the pore channels of MSNs, and functionalized the MSNs surface with ROS-responsive methylthiopropyl groups. The released CeO 2 NPs could scavenge more than 80% of H 2 O 2 within 10 min in an ROS-excess environment, which was demonstrated to be a potentially secure and productive antioxidant therapeutic agent. 437
What is the difference between fumed silica and precipitated silica?
quartz sand shortage Carmona, D., Balas, F. & Santamaria, J. Pore ordering and surface properties of FDU-12 and SBA-15 mesoporous materials and their relation to drug loading and release in aqueous environments. Mater. Res. Bull. 59, 311-322 (2014). Post CAS Google Scholar
What drives silica raw material prices?
spherical vs angular silica Gupta, J. et al. Nanoparticle formulations in the diagnosis and therapy of Alzheimer's illness. Int. J. Biol. Macromol. 130, 515-526 (2019). Post CAS PubMed Google Scholar
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.